2022
DOI: 10.1039/d1nr05601h
|View full text |Cite
|
Sign up to set email alerts
|

Bio-engineered nano-vesicles for IR820 delivery: a therapy platform for cancer by surgery and photothermal therapy

Abstract: Long-term unsolved health problems from pre-/Intra-/postoperative complications and thermal ablation complications pose threats to liver cancer patients. To reduce the threats, we propose a multimodal-imaging guided surgical navigation system...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(6 citation statements)
references
References 56 publications
(71 reference statements)
0
6
0
Order By: Relevance
“…323 Due to the target delivery of cell membrane nanoparticles, multifunctional modification strategies based on cell membrane biomimetic nanoparticles include noncovalent coating and chemical modification. [324][325][326] Due to the biocompatibility of the cell membrane, the cell membrane can be coated on the photothermal materials to form a core-shell structure, such as Pt, Au, 327 IR780, 328 and IR820 329 . For example, Zhai et al 330 prepared a traceable bioinspired nanovesicle (MPV) based on a cell membrane-derived shell.…”
Section: Cell Membrane Biomimetic Nanoparticlesmentioning
confidence: 99%
“…323 Due to the target delivery of cell membrane nanoparticles, multifunctional modification strategies based on cell membrane biomimetic nanoparticles include noncovalent coating and chemical modification. [324][325][326] Due to the biocompatibility of the cell membrane, the cell membrane can be coated on the photothermal materials to form a core-shell structure, such as Pt, Au, 327 IR780, 328 and IR820 329 . For example, Zhai et al 330 prepared a traceable bioinspired nanovesicle (MPV) based on a cell membrane-derived shell.…”
Section: Cell Membrane Biomimetic Nanoparticlesmentioning
confidence: 99%
“…[ 122 ] Taken one step further, IR820 is usually encapsulated in nanostructures (such as inorganic Fe@CaCO 3 and organic nanocapsules), further delivering it to the tumor area through targeted delivery and high‐concentration accumulation, as well as it can be utilized as a multimodal reagent in imaging and clinical application during low infrared light (808 nm laser, 1.0 W·cm −2 ). [ 123,124 ] The strong drug toxicity makes IR820 induce the heat‐lethal effect of liver cancer both in vivo and in vitro, in which mild PTT‐induced local hyperthermia kills immunogenic cells, resulting in hypersensitivity of tumors to immune checkpoint inhibitors, thereby improving the efficiency of HCC hyperthermia.…”
Section: Different Ptas Commonly Used In Ptt Toward Hccmentioning
confidence: 99%
“…Reproduced with permission. [ 124 ] Copyright 2022, Royal Society of Chemistry. b) Schematic illustration of the preparation of ferrimagnetic silk fibroin hydrogel (FSH).…”
Section: Combinational Photothermal Therapy and Other Therapy Toward Hccmentioning
confidence: 99%
See 1 more Smart Citation
“…The design and preparation of multifunctional nanoplatforms with integrated functions have aroused extensive interest among nanobiotechnologists. Recently, an increasing number of diagnostic nanoprobes have been developed based on inorganic, organic, and organic/inorganic nanomaterials for image-guided photodynamic therapy (PTT), photothermal therapy (PDT), and acoustic therapy of cancer. In addition to these laser or ultrasound-mediated therapies, there are also chemodynamic therapy (CDT) that produce singlet states to kill tumor cells by Fenton or Fenton-like reaction in the presence of H 2 O 2 . , The surface functional groups of these nanomaterials ( e.g. , inorganic materials) are relatively easy to modify, which can be used to encapsulate drugs and are equipped with a variety of imaging/healing properties. Although they have excellent therapeutic efficacy in animal models, their inherent low biodegradation is a serious obstacle to their clinical use.…”
Section: Introductionmentioning
confidence: 99%